About BioQ Pharma
BioQ Pharma is a company based in United States founded in 2003.. BioQ Pharma has raised $84.58 million across 11 funding rounds from investors including IIG PLC, Madryn Asset Management and Military Health. The company has 15 employees as of December 31, 2020. BioQ Pharma offers products and services including invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol. BioQ Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Insulet, Neurocrine and PTC Therapeutics, among others.
- Headquarter United States
- Employees 15 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioq Pharma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$84.58 M (USD)
in 11 rounds
-
Latest Funding Round
$4.64 M (USD), Series D
Jan 10, 2020
-
Investors
IIG PLC
& 2 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioQ Pharma
BioQ Pharma offers a comprehensive portfolio of products and services, including invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Transforms infusible medicines into ready-to-use systems for safer administration.
Provides tailored delivery for the Ropivacaine drug.
Offers connect-and-go solution for propofol administration.
Unlock access to complete
Funding Insights of BioQ Pharma
BioQ Pharma has successfully raised a total of $84.58M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $4.64 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series D — $4.6M
-
First Round
First Round
(01 Feb 2004)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series D - BioQ Pharma | Valuation | IIG |
|
| Nov, 2018 | Amount | Series D - BioQ Pharma | Valuation | Madryn Asset Management |
|
| Oct, 2016 | Amount | Series C - BioQ Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioQ Pharma
BioQ Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IIG PLC, Madryn Asset Management and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by IIG toward life sciences startups.
|
Founded Year | Domain | Location | |
|
Diversified asset management is provided by the firm.
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioQ Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioQ Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioq Pharma Comparisons
Competitors of BioQ Pharma
BioQ Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Insulet, Neurocrine and PTC Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioq Pharma
Frequently Asked Questions about BioQ Pharma
When was BioQ Pharma founded?
BioQ Pharma was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Where is BioQ Pharma located?
BioQ Pharma is headquartered in United States.
Is BioQ Pharma a funded company?
BioQ Pharma is a funded company, having raised a total of $84.58M across 11 funding rounds to date. The company's 1st funding round was a Series C of $15.04M, raised on Feb 01, 2004.
How many employees does BioQ Pharma have?
As of Dec 31, 2020, the latest employee count at BioQ Pharma is 15.
What does BioQ Pharma do?
BioQ Pharmanbsp;(formerly known as BioQuiddity)nbsp;is a late-stage specialty pharmaceutical company focused onnbsp;the portfolio of large volume ready-to-use infusible pharmaceuticals using its infusion platform. The platform includes a unit dose of the drug, delivery system and administration line in one self-contained and ready-to-use presentation.nbsp;Its lead products include Ropivacaine (approved in EU) and Propofol for post-surgical pain and anesthesia. Additionally, it has four products in the development stage for sedation, antibiotics and oncology.
Who are the top competitors of BioQ Pharma?
BioQ Pharma's top competitors include Jazz Pharmaceuticals, Insulet and PTC Therapeutics.
What products or services does BioQ Pharma offer?
BioQ Pharma offers invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol.
Who are BioQ Pharma's investors?
BioQ Pharma has 3 investors. Key investors include IIG PLC, Madryn Asset Management, and Military Health.